Genxone (WAR:GX1) ROE % Adjusted to Book Value : -26.76% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Genxone ROE % Adjusted to Book Value?

Genxone's ROE % for the quarter that ended in Dec. 2024 was -49.78%. Genxone's PB Ratio for the quarter that ended in Dec. 2024 was 1.86. Genxone's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -26.76%.

Genxone ROE % Adjusted to Book Value Historical Data

The historical data trend for Genxone's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genxone ROE % Adjusted to Book Value Chart

Genxone Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

16.51

14.98

1.33

-18.57

-16.27

Genxone Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-17.45	-16.86	-15.79	-15.62	-26.76

Competitive Comparison of Genxone's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Genxone's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genxone's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genxone's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Genxone's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Genxone ROE % Adjusted to Book Value Calculation

Genxone's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-30.27%	/	1.86
	=	-16.27%

Genxone's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-49.78%	/	1.86
	=	-26.76%

Genxone ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Genxone's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Genxone Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Kobaltowa 6, Zlotniki, Suchy Las, POL, 62-002

Website

https://www.genxone.eu

Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.

Genxone Headlines

No Headlines